Edesa Biotech Schedule 13G: 5.4% Stake Reported

Rhea-AI Filing Summary

Edesa Biotech, Inc. Schedule 13G shows a group of related filers including Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander reporting shared beneficial ownership of 520,685 shares, equal to 5.4% of the company’s common stock. The filing bases the percent on 9,621,192 Common Shares outstanding, composed of 8,891,951 shares as of May 13, 2026 and 729,241 shares issued in a private placement that closed on or about June 15, 2026. The filing is a joint filing under a Joint Filing Agreement dated June 17, 2026 and describes shared voting and dispositive power rather than sole control.

Insights

Corporate Governance Analyst

Joint filing reports a 5.4% shared stake via related Millennium entities.

The schedule lists 520,685 shares (5.4%) reported as shared voting and dispositive power among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. The percentage uses an outstanding share base of 9,621,192 shares.

Ownership is presented as held by entities subject to manager/trustee control; the filing clarifies this structure and includes a Joint Filing Agreement. Future disclosure of any changes would appear in subsequent ownership filings.

Equity Markets Specialist

Position size and timing are explicitly tied to a recent private placement.

The calculation cites 8,891,951 shares outstanding as of May 13, 2026 plus 729,241 shares from a private placement that closed on or about June 15, 2026, producing a 9,621,192-share base. The filing therefore reflects post-placement ownership math.

Cash‑flow treatment and any planned dispositions are not detailed in the excerpt; subsequent Section 13 filings would report transaction direction or changes in holdings.

Key Figures

Reported shares: 520,685 shares Percent of class: 5.4% Shares outstanding (basis): 9,621,192 shares +2 more

5 metrics

Reported shares 520,685 shares shared beneficial ownership reported on Schedule 13G

Percent of class 5.4% calculated percent of common stock

Shares outstanding (basis) 9,621,192 shares sum of outstanding as of <date> and private placement (basis for percent)

Shares outstanding as of May 13, 2026 8,891,951 shares reported in issuer's Form 10-Q filed May 14, 2026

Private placement shares 729,241 shares issued in private placement closed on or about June 15, 2026

Key Terms

Schedule 13G, beneficially owned, Joint Filing Agreement, shared dispositive power

4 terms

Schedule 13G regulatory

"Schedule 13G shows a group of related filers including Integrated Core Strategies"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficially owned financial

"Amount beneficially owned: See response to Item 9 on each cover page"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Joint Filing Agreement regulatory

"Exhibit I: Joint Filing Agreement, dated as of June 17, 2026"

shared dispositive power financial

"Shared Dispositive Power 520,685.00 on each cover page"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Millennium report in EDSA?

The filing reports 520,685 shares, equal to 5.4% of common stock. This percentage is calculated using 9,621,192 shares outstanding after a private placement closed on or about June 15, 2026.

Which entities joined the joint filing for Edesa Biotech (EDSA)?

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander executed a Joint Filing Agreement dated June 17, 2026 and filed the Schedule 13G together.

How did the filing calculate percent ownership for EDSA?

Percent ownership used a base of 9,621,192 Common Shares outstanding, derived from 8,891,951 shares as of May 13, 2026 plus 729,241 shares issued in a private placement closing on or about June 15, 2026.

Does the Schedule 13G show sole control of the reported shares?

No. The filing shows shared voting and dispositive power over the 520,685 shares, with zeros for sole voting and sole dispositive power on the cover pages.

When was the joint filing signed for Edesa Biotech (EDSA)?

The Joint Filing Agreement and the signatures on the Schedule 13G are dated June 17, 2026, as shown on the exhibit and cover-page signings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 05:05 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Edesa Biotech, Inc.

(Name of Issuer)

Common Shares, without par value

(Title of Class of Securities)

27966L306

(CUSIP Number)

06/11/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 27966L306

1

Names of Reporting Persons

Integrated Core Strategies (US) LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 520,685.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 520,685.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

520,685.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 27966L306

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 520,685.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 520,685.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

520,685.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 27966L306

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 520,685.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 520,685.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

520,685.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 27966L306

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 520,685.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 520,685.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

520,685.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Edesa Biotech, Inc.
(b)	Address of issuer's principal executive offices: 100 Spy Court, Markham, Ontario, Canada L3R 5H6
Item 2.
(a)	Name of person filing: Integrated Core Strategies (US) LLC Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Integrated Core Strategies (US) LLC c/o Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Integrated Core Strategies (US) LLC - Delaware Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Common Shares, without par value
(e)	CUSIP Number(s): 27966L306
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page. The percent of class was calculated based on 9,621,192 Common Shares outstanding, which is the sum of (i) 8,891,951 Common Shares outstanding as of May 13, 2026, as reported in the issuer's Form 10-Q filed with the SEC on May 14, 2026, and (ii) 729,241 Common Shares issued in connection with a private placement that closed on or about June 15, 2026, as reported in the issuer's Form 8-K filed with the SEC on June 11, 2026.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. See Exhibit I
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Integrated Core Strategies (US) LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	06/17/2026

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	06/17/2026

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	06/17/2026

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	06/17/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of June 17, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.